Drugs / α-Tocopherol
α-Tocopherol
English name Vitamin E
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT07412574 | Sep 2020 → Sep 2021 | COVID-19 | Universidad Veracruzana | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT06634056 | Jun 2026 → Nov 2031 expected | non-small cell lung carcinoma, radiation pneumonitis | University Health Network, Toronto | Recruiting | No outcome recorded |
| Phase 2 | NCT00188552 | Jul 2002 → ? | — | University Health Network, Toronto | Terminated | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01544192 Comparator | Apr 2008 → Nov 2009 | glaucoma | Bagcilar Training and Research Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | α-Tocopherol | “The drug Pentoxifylline (in combination with α-Tocopherol (Vitamin E)) has been shown to prevent/alter the progression of lung injury” NCT06634056 ↗ |
| Known as | alpha-tocopherol | “α-Tocopherol (alpha-tocopherol)” NCT07412574 ↗ |
| Known as | vitamin E | “The drug Pentoxifylline (in combination with α-Tocopherol (Vitamin E)) has been shown to prevent/alter the progression of lung injury” NCT06634056 ↗1“vitamin E (alpha-tocopherol)” NCT07412574 ↗ |
| Route | Oral | “α-Tocopherol 400 IU orally two times a day” NCT06634056 ↗ |